Toward a comprehensive neurobiology of IGF-I

Developmental Neurobiology

Volumn 70, Issue 5, 2010, Pages 384-396

  Torres Aleman, Ignacio ^a,b  

^a INSTITUTO CAJAL   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Adult brain; Insulin like growth factor; Neuroprotection

Indexed keywords

AMYLOID PROTEIN; GROWTH FACTOR; HORMONE; NEUROTROPHIC FACTOR; SOMATOMEDIN C;

ANGIOGENESIS; BODY GROWTH; BRAIN CELL; BRAIN FUNCTION; BRAIN GROWTH; BRAIN METABOLISM; BRAIN REGION; CELL PROTECTION; CELL TYPE; COGNITION; ELECTROENCEPHALOGRAM; HUMAN; INVERTEBRATE; MAMMAL; MEMBRANE CHANNEL; NERVE CELL; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANIMALS; BRAIN; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MODELS, NEUROLOGICAL;

EID: 77949741721     PISSN: 19328451     EISSN: 10974695     Source Type: Journal    
DOI: 10.1002/dneu.20778     Document Type: Review

References (118)

1. Adamo ML, Ma X, Ackert Bicknell CL, Donahue LR, Beamer WG, Rosen CJ. 2006. Genetic increase in serum insulin-like growth factor-I (IGF-I) in C3H/HeJ compared to C57BL/6J mice is associated with increased transcription from the IGF-I exon 2 promoter. Endocrinology 147:2944-2955.
2. Albiston AL, Herington AC. 1992. Tissue distribution and regulation of insulin-like growth factor (IGF)-binding protein-3 messenger ribonucleic acid (mRNA) in the rat: Comparison with IGF-I mRNA expression. Endocrinology 130:497-502.
3. Aleman A, Torres-Aleman I. 2009. Circulating insulin-like growth factor I and cognitive function: Neuromodulation throughout the lifespan. Prog Neurobiol 89:256-265.
4. Aleman A, Verhaar HJ, de Haan EH, de Vries WR, Samson MM, Drent ML, van der Veen EA, et al. 1999. Insulin-like growth factor-I and cognitive function in healthy older men. J Clin Endocrinol Metab 84:471-475.
5. Arancio O, Chao MV. 2007. Neurotrophins, synaptic plasticity and dementia. Curr Opin Neurobiol 17:325-330.
6. Arantes-Oliveira N, Berman JR, Kenyon C. 2003. Healthy animals with extreme longevity. Science 302:611.
7. Bach MA, Shen-Orr Z, Lowe WL Jr, Roberts CT Jr, LeRoith D. 1991. Insulin-like growth factor I mRNA levels are developmentally regulated in specific regions of the rat brain. Brain Res Mol Brain Res 10:43-48.
8. Bates KA, Verdile G, Li QX, Ames D, Hudson P, Masters CL, Martins RN. 2009. Clearance mechanisms of Alzheimer's amyloid-beta peptide: Implications for therapeutic design and diagnostic tests. Mol Psychiatry 14:469-486.
9. Baura GD, Foster DM, Porte D Jr, Kahn SE, Bergman RN, Cobelli C, Schwartz MW. 1993. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest 92:1824-1830.
10. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. 2009. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 30:586-623.
11. Belgardt BF, Okamura T, Bruning JC. 2009. Hormone and glucose signaling in POMC and AgRP neurons. J Physiol 587 (Part 22):5305-5314.
12. Binoux M, Roghani M, Hossenlopp P, Whitechurch O. 1991. Cerebrospinal IGF binding proteins: Isolation and characterization. Adv Exp Med Biol 293:161-170.
13. Bondy CA. 1991. Transient IGF-I gene expression during the maturation of functionally related central projection neurons. J Neurosci 11:3442-3455.
14. Bondy CA, Lee WH. 1993. Patterns of insulin-like growth factor and IGF receptor gene expression in the brain. Functional implications. Ann N Y Acad Sci 692:33-43.
15. Bozzola M, Travaglino P, Marziliano N, Meazza C, Pagani S, Grasso M, Tauber M, et al. 2009. The shortness of Pygmies is associated with severe under-expression of the growth hormone receptor. Mol Genet Metab 98:310-313.
16. Brahm H, Piehl-Aulin K, Saltin B, Ljunghall S. 1997. Net fluxes over working thigh of hormones, growth factors and biomarkers of bone metabolism during short lasting dynamic exercise. Calcif Tissue Int 60:175-180.
17. Brar AK, Chernausek SD. 1993. Localization of insulin-like growth factor binding protein-4 expression in the developing and adult rat brain: Analysis by in situ hybridization. J Neurosci Res 35:103-114.
18. Breese CR, Ingram RL, Sonntag WE. 1991. Influence of age and long-term dietary restriction on plasma insulin-like growth factor-1 (IGF-1), IGF-1 gene expression, and IGF-1 binding proteins. J Gerontol 46:B180-B187.
19. Brogiolo W, Stocker H, Ikeya T, Rintelen F, Fernandez R, Hafen E. 2001. An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Curr Biol 11:213-221.
20. Brugts MP, Van den Beld AW, Hofland LJ, van der WK, van Koetsveld PM, Frystyk J, Lamberts SW, et al. 2008. Low circulating IGF-I bioactivity in elderly men is associated with increased mortality. J Clin Endocrinol Metab 93:2515-2522.
21. Busiguina S, Fernandez AM, Barrios V, Clark R, Tolbert DL, Berciano J, Torres-Aleman I. 2000. Neurodegeneration is associated to changes in serum insulin-like growth factors. Neurobiol Dis 7:657-665.
22. Butler AA, Yakar S, LeRoith D. 2002. Insulin-like growth factor-I: Compartmentalization within the somatotropic axis? News Physiol Sci 17:82-85.
23. Cardona-Gomez GP, Chowen JA, Garcia-Segura LM. 2000. Estradiol and progesterone regulate the expression of insulin-like growth factor-I receptor and insulin-like growth factor binding protein-2 in the hypothalamus of adult female rats. J Neurobiol 43:269-281.
24. Carro E, Nunez A, Busiguina S, Torres-Aleman I. 2000. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci 20:2926-2933.
25. Carro E, Spuch C, Trejo JL, Antequera D, Torres-Aleman I. 2005. Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I. J Neurosci 25:10884-10893.
26. Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I. 2002. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 8:1390-1397.
27. Chan SJ, Cao QP, Steiner DF. 1990. Evolution of the insulin superfamily: Cloning of a hybrid insulin/insulin-like growth factor cDNA from amphioxus. Proc Natl Acad Sci USA 87:9319-9323.
28. Chen RL, Kassem NA, Sadeghi M, Preston JE. 2008. Insulin-like growth factor-II uptake into choroid plexus and brain of young and old sheep. J Gerontol A Biol Sci Med Sci 63:141-148.
29. Clark CM, Karlawish JH. 2003. Alzheimer disease: Current concepts and emerging diagnostic and therapeutic strategies. Ann Intern Med 138:400-410.
30. D'Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G. 1996. The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 13:227-255.
31. Davila D, Piriz J, Trejo JL, Nunez A, Torres-Aleman I. 2007. Insulin and insulin-like growth factor I signalling in neurons. Front Biosci 12:3194-3202.
32. Deane R, Wu Z, Sagare A, Davis J, Du YS, Hamm K, Xu F, et al. 2004. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43:333-344.
33. Deijen JB, de Boer H, Blok GJ, van der Veen EA. 1996. Cognitive impairments and mood disturbances in growth hormone deficient men. Psychoneuroendocrinology 21:313-322.
34. Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, Forbes B, Roberts CT Jr. 2007. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Mol Cell Biol 27:3569-3577.
35. Dietrich MO, Muller A, Bolos M, Carro E, Perry ML, Portela LV, Souza DO, et al. 2007. Western style diet impairs entrance of blood-borne insulin-like growth factor-1 into the brain. Neuromolecular Med 9:324-330.
36. Ding Q, Vaynman S, Akhavan M, Ying Z, Gomez-Pinilla F. 2006. Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function. Neuroscience 140:823-833.
37. Dore S, Bastianetto S, Kar S, Quirion R. 1999. Protective and rescuing abilities of IGF-I and some putative free radical scavengers against beta-amyloid-inducing toxicity in neurons. Ann N Y Acad Sci 890:356-364.
38. Dunger DB, Ong KK, Sandhu MS. 2003. Serum insulin-like growth factor-I levels and potential risk of type 2 diabetes. Horm Res 60 (Suppl 3):131-135.
39. Fernandez AM, Kim JK, Yakar S, Dupont J, Hernandez-Sanchez C, Castle AL, Filmore J, et al. 2001. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev 15:1926-1934.
40. Fernandez-Galaz MC, Torres-Aleman I, Garcia-Segura LM. 1996. Endocrine-dependent accumulation of IGF-I by hypothalamic glia. Neuroreport 8:373-377.
41. Firth SM, Baxter RC. 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854.
42. Foster LA, Ames NK, Emery RS. 1991. Food intake and serum insulin responses to intraventricular infusions of insulin and IGF-I. Physiol Behav 50:745-749.
43. Frank HJ, Pardridge WM, Morris WL, Rosenfeld RG, Choi TB. 1986. Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels. Diabetes 35:654-661.
44. Freude S, Hettich MM, Schumann C, Stohr O, Koch L, Kohler C, Udelhoven M, et al. 2009. Neuronal IGF-1 resistance reduces A{beta} accumulation and protects against premature death in a model of Alzheimer's disease. FASEB J 23:3315-3324.
45. Friedrich N, Haring R, Nauck M, Ludemann J, Rosskopf D, Spilcke-Liss E, Felix SB, et al. 2009. Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. J Clin Endocrinol Metab 94:1732-1739.
46. Garcia-Segura LM, Perez J, Pons S, Rejas MT, Torres-Aleman I. 1991. Localization of insulin-like growth factor I (IGF-I)-like immunoreactivity in the developing and adult rat brain. Brain Res 560:167-174.
47. Giuffrida ML, Caraci F, Pignataro B, Cataldo S, De Bona P, Bruno V, Molinaro G, et al. 2009. Beta-amyloid monomers are neuroprotective. J Neurosci 29:10582-10587.
48. Gonda Y, Sakurai H, Hirata Y, Tabata H, Ajioka I, Nakajima K. 2007. Expression profiles of Insulin-like growth factor binding protein-like 1 in the developing mouse forebrain. Gene Expr Patterns 7:431-440.
49. Govoni KE, Wergedal JE, Florin L, Angel P, Baylink DJ, Mohan S. 2007. Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion. Endocrinology 148:5706-5715.
50. Harper JM, Durkee SJ, Dysko RC, Austad SN, Miller RA. 2006. Genetic modulation of hormone levels and life span in hybrids between laboratory and wild-derived mice. J Gerontol A Biol Sci Med Sci 61:1019-1029.
51. Hawkes C, Kar S. 2004. The insulin-like growth factor-II/mannose-6- phosphate receptor: Structure, distribution and function in the central nervous system. Brain Res Brain Res Rev 44:117-140.
52. Hill JM, Lesniak MA, Pert CB, Roth J. 1986. Autoradiographic localization of insulin receptors in rat brain: Prominence in olfactory and limbic areas. Neuroscience 17:1127-1138.
53. Holloszy JO. 2005. Exercise-induced increase in muscle insulin sensitivity. J Appl Physiol 99:338-343.
54. Kappeler L, De Magalhaes Filho CM, Dupont J, Leneuve P, Cervera P, Perin L, Loudes C, et al. 2008a. Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism. PLoS Biol 6:e254.
55. Kappeler L, De Magalhaes FC, Leneuve P, Xu J, Brunel N, Chatziantoniou C, Le BY, et al. 2008b. Early postnatal nutrition determines somatotropic function in mice. Endocrinology 150:314-323.
56. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. 1993. A C. elegans mutant that lives twice as long as wild type. Nature 366:461-464.
57. Korsching S. 1993. The neurotrophic factor concept: A reexamination. J Neurosci 13:2739-2748.
58. Landi S, Ciucci F, Maffei L, Berardi N, Cenni MC. 2009. Setting the pace for retinal development: Environmental enrichment acts through insulin-like growth factor 1 and brain-derived neurotrophic factor. J Neurosci 29:10809-10819.
59. Lee HK, Kumar P, Fu Q, Rosen KM, Querfurth HW. 2009a. The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid. Mol Biol Cell 20:1533-1544.
60. Lee SA, Chan CH, Chen TC, Yang CY, Huang KC, Tsai CH, Lai JM, et al. 2009b. POINeT: Protein interactome with sub-network analysis and hub prioritization. BMC Bioinformatics 10:114.
61. Lee WH, Javedan S, Bondy CA. 1992. Coordinate expression of insulin-like growth factor system components by neurons and neuroglia during retinal and cerebellar development. J Neurosci 12:4737-4744.
62. Lee WH, Michels KM, Bondy CA. 1993. Localization of insulin-like growth factor binding protein-2 messenger RNA during postnatal brain development: Correlation with insulin-like growth factors I and II. Neuroscience 53:251-265.
63. Lee WH, Wang GM, Lo T, Triarhou LC, Ghetti B. 1995. Altered IGFBP5 gene expression in the cerebellar external germinal layer of weaver mutant mice. Brain Res Mol Brain Res 30:259-268.
64. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. 1995. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163.
65. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. 2009. Soluble oligomers of amyloid beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62:788-801.
66. Li Y, Xu W, McBurney MW, Longo VD. 2008. SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab 8:38-48.
67. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72.
68. Liu W, Ye P, O'Kusky JR, D'Ercole AJ. 2009. Type 1 insulin-like growth factor receptor signaling is essential for the development of the hippocampal formation and dentate gyrus. J Neurosci Res 87:2821-2832.
69. Lopez-Lopez C, LeRoith D, Torres-Aleman I. 2004. Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc Natl Acad Sci USA 101:9833-9838.
70. Malito E, Hulse RE, Tang WJ. 2008. Amyloid beta-degrading cryptidases: Insulin degrading enzyme, presequence peptidase, and neprilysin. Cell Mol Life Sci 65:2574-2585.
71. Marks JL, Porte D Jr, Baskin DG. 1991. Localization of type I insulin-like growth factor receptor messenger RNA in the adult rat brain by in situ hybridization. Mol Endocrinol 5:1158-1168.
72. McRory JE, Sherwood NM. 1997. Ancient divergence of insulin and insulin-like growth factor. DNA Cell Biol 16:939-949.
73. Moxham CP, Duronio V, Jacobs S. 1989. Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. J Biol Chem 264:13238-13244.
74. Muzumdar RH, Ma X, Fishman S, Yang X, Atzmon G, Vuguin P, Einstein FH, et al. 2006. Central and opposing effects of IGF-I and IGF-binding protein-3 on systemic insulin action. Diabetes 55:2788-2796.
75. Naeve GS, Vana AM, Eggold JR, Verge G, Ling N, Foster AC. 2000. Expression of rat insulin-like growth factor binding protein-6 in the brain, spinal cord, and sensory ganglia. Brain Res Mol Brain Res 75:185-197.
76. Niedernhofer LJ, Garinis GA, Raams A, Lalai AS, Robinson AR, Appeldoorn E, Odijk H, et al. 2006. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 444:1038-1043.
77. Nunez A, Carro E, Torres-Aleman I. 2003. Insulin-like growth factor I modifies electrophysiological properties of rat brain stem neurons. J Neurophysiol 89:3008-3017.
78. Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L. 2002. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 5:566-572.
79. Ocrant I, Fay CT, Parmelee JT. 1990. Characterization of insulin-like growth factor binding proteins produced in the rat central nervous system. Endocrinology 127:1260-1267.
80. Pardini AW, Nguyen HT, Figlewicz DP, Baskin DG, Williams DL, Kim F, Schwartz MW. 2006. Distribution of insulin receptor substrate-2 in brain areas involved in energy homeostasis. Brain Res 1112:169-178.
81. Pardridge WM. 1993. Transport of insulin-related peptides and glucose across the blood-brain barrier. Ann N Y Acad Sci 692:126-137.
82. Park JY, Cho MO, Leonard S, Calder B, Mian IS, Kim WH, Wijnhoven S, et al. 2008. Homeostatic imbalance between apoptosis and cell renewal in the liver of premature aging Xpd mice. PLoS One 3:e2346.
83. Porte D Jr, Baskin DG, Schwartz MW. 2005. Insulin signaling in the central nervous system: A critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 54:1264-1276.
84. Purves D, Lichtman JW. 1980. Elimination of synapses in the developing nervous system. Science 210:153-157.
85. Reinhardt RR, Bondy CA. 1994. Insulin-like growth factors cross the blood-brain barrier. Endocrinology 135:1753-1761.
86. Richards M, Deary IJ. 2005. A life course approach to cognitive reserve: A model for cognitive aging and development? Ann Neurol 58:617-622.
87. Roy CS, Sherrington CS. 1890. On the regulation of the blood-supply of the brain. J Physiol 11:85-158.
88. Ruiz-Torres A, Soares De Melo KM. 2002. Ageing and longevity are related to growth hormone/insulin-like growth factor-1 secretion. Gerontology 48:401-407.
89. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ. 2002. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: A prospective observational study. Lancet 359:1740-1745.
90. Sharma S, Prasanthi RPJ, Schommer E, Feist G, Ghribi O. 2008. Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling. Neurobiol Dis 32:426-432.
91. Shelmadine B, Cooke M, Buford T, Hudson G, Redd L, Leutholtz B, Willoughby DS. 2009. Effects of 28 days of resistance exercise and consuming a commercially available pre-workout supplement. NO-Shotgun(R), on body composition, muscle strength and mass, markers of satellite cell activation, and clinical safety markers in males. J Int Soc Sports Nutr 6:16.
92. Slaaby R, Schaffer L, Lautrup-Larsen I, Andersen AS, Shaw AC, Mathiasen IS, Brandt J. 2006. Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant. J Biol Chem 281:25869-25874.
93. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, et al. 2005. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8:1051-1058.
94. Stenvers KL, Zimmermann EM, Gallagher M, Lund PK. 1994. Expression of insulin-like growth factor binding protein-4 and -5 mRNAs in adult rat forebrain. J Comp Neurol 339:91-105.
95. Suh Y, Atzmon G, Cho MO, Hwang D, Liu B, Leahy DJ, Barzilai N, et al. 2008. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci USA 105:3438-3442.
96. Suzuki T, Nakaya T. 2008. Regulation of amyloid beta-protein precursor by phosphorylation and protein interactions. J Biol Chem 283:29633-29637.
97. Thissen JP, Ketelslegers JM, Underwood LE. 1994. Nutritional regulation of the insulin-like growth factors. Endocr Rev 15:80-101.
98. Torres-Aleman I. 2005. Role of insulin-like growth factors in neuronal plasticity and neuroprotection. Adv Exp Med Biol 567:243-258.
99. Torres-Aleman I. 1999. Insulin-like growth factors as mediators of functional plasticity in the adult brain. Horm Metab Res 31:114-119.
100. Torres-Aleman I. 2000. Serum growth factors and neuroprotective surveillance. Mol Neurobiol 21:153-160.
101. Torres-Aleman I, Pons S, Arevalo MA. 1994. The insulin-like growth factor I system in the rat cerebellum: Developmental regulation and role in neuronal survival and differentiation. J Neurosci Res 39:117-126.
102. Trejo JL, Carro E, Garcia-Galloway E, Torres-Aleman I. 2004. Role of insulin-like growth factor I signaling in neurodegenerative diseases. J Mol Med 82:156-162.
103. Trejo JL, Carro E, Nunez A, Torres-Aleman I. 2002. Sedentary life impairs self-reparative processes in the brain: The role of serum insulin-like growth factor-I. Rev Neurosci 13:365-374.
104. Trejo JL, Carro E, Torres-Aleman I. 2001. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci 21:1628-1634.
105. Trejo JL, Llorens-Martin MV, Torres-Aleman I. 2008. The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis. Mol Cell Neurosci 37:402-411.
106. Vale RG, de Oliveira RD, Pernambuco CS, de Meneses YP, Novaes JD, de Andrade AD. 2009. Effects of muscle strength and aerobic training on basal serum levels of IGF-1 and cortisol in elderly women. Arch Gerontol Geriatr 49:343-347.
107. Vallejo AN, Michel JJ, Bale LK, Lemster BH, Borghesi L, Conover CA. 2009. Resistance to age-dependent thymic atrophy in long-lived mice that are deficient in pregnancy-associated plasma protein A. Proc Natl Acad Sci USA 106:11252-11257.
108. van der Pluijm I, Garinis GA, Brandt RM, Gorgels TG, Wijnhoven SW, Diderich KE, de Wit J, et al. 2007. Impaired genome maintenance suppresses the growth hormone-insulin-like growth factor 1 axis in mice with Cockayne syndrome. PLoS Biol 5:e2.
109. Velloso CP. 2008. Regulation of muscle mass by growth hormone and IGF-I. Br J Pharmacol 154:557-568.
110. Wallis M. 2008. New insulin-like growth factor (IGF)-precursor sequences from mammalian genomes: The molecular evolution of IGFs and associated peptides in primates. Growth Horm IGF Res 19:12-23.
111. Walter HJ, Berry M, Hill DJ, Logan A. 1997. Spatial and temporal changes in the insulin-like growth factor (IGF) axis indicate autocrine/paracrine actions of IGF-I within wounds of the rat brain. Endocrinology 138:3024-3034.
112. Wilczak N, de Vos RA, De Keyser J. 2003. Free insulin-like growth factor (IGF)-I and IGF binding proteins 2, 5, and 6 in spinal motor neurons in amyotrophic lateral sclerosis. Lancet 361:1007-1011.
113. Wu Y, Sun H, Yakar S, LeRoith D. 2009. Elevated levels of IGF-1 in serum rescue the severe growth retardation of IGF-1 null mice. Endocrinology 150:4395-4403.
114. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D. 1999. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96:7324-7329.
115. Yakar S, Wu Y, Setser J, Rosen CJ. 2002. The role of circulating IGF-I: Lessons from human and animal models. Endocrine 19:239-248.
116. Yan Z, Biggs RB, Booth FW. 1993. Insulin-like growth factor immunoreactivity increases in muscle after acute eccentric contractions. J Appl Physiol 74:410-414.
117. Ye P, D'Ercole J. 1998. Insulin-like growth factor I (IGF-I) regulates IGF binding protein-5 gene expression in the brain. Endocrinology 139:65-71.
118. Zhao WQ, Lacor PN, Chen H, Lambert MP, Quon MJ, Krafft GA, Klein WL. 2009. Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric A{beta}. J Biol Chem 284:18742-18753.